Salmones Camanchaca S.A (SALMOCAM) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Salmones Camanchaca S.A CLP 3,961, price CLP 5,100, upside -22.3%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Salmones Camanchaca S.A for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 1,759 CLP – 5,496 CLP · fair‑value band 2,518 CLP – 6,202 CLP · the 5,100 CLP price screens above the 3,961 CLP fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.
Follow Salmones Camanchaca in your weekly email
Every Wednesday you see whether Salmones Camanchaca is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic salmon, including whole/HG, steak, servings, and other products; and whole/HG coho, coho steak, and coho portions. It also exports its products. The company was founded in 1987 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A.
Show more
Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic salmon, including whole/HG, steak, servings, and other products; and whole/HG coho, coho steak, and coho portions. It also exports its products. The company was founded in 1987 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. operates as a subsidiary of Camanchaca S.A.
Stock analysis
Salmones Camanchaca S.A (SALMOCAM) currently trades at 5,100 CLP, while our model-based Fair Value estimate is 3,961 CLP, implying the stock looks roughly 28.7% overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 6,565 CLP per share, and 9 of the 20 models we run sit above the 5,100 CLP price.
Bear case: the Asset-Based group reads lowest at 2,031 CLP, and 11 of the 20 models stay below the price. Evidence for this calculation is high.
Scenario range: 2,518 CLP (bear) to 6,202 CLP (bull), the price of 5,100 CLP sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Salmones Camanchaca S.A reported revenue of $386M in FY2025 versus $294M in FY2021, a compound +7.1%/yr. Reported net income was $25.5M in FY2025.
Key figures
Market cap 378B CLP (≈ $394M) · P/E ratio 23.7 · P/S ratio 1.57 · EPS (TTM) 214.93 CLP · Dividend yield 0.0% · Net margin 6.6% · Return on equity 8.2% · Return on assets (EBIT) 5.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 3% below its 52-week high and 49% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −22%, SALMOCAM screens richer than that median.
Fair Value models
Bear 2,518 CLPFair Value 3,961 CLPBull 6,202 CLP
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (157.74 CLP per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.51/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−4.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.6%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.3%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−11.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−11.7%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−15% → 12%
Growth Forecast
A lot of optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
more than +80 %
Yearly growth needed for the next five years to justify today's price.
Compare Salmones Camanchaca S.A with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 296 stocks
Beats the industry median on 4/14 measures
Overall it trails its industry peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside−22% · Below median
Profitability
Return on equity (TTM)8% · Above median
Return on assets5% · Above median
Net margin (TTM)5% · Above median
Operating margin (TTM)−3% · Bottom 25%
Growth and dividend
Revenue growth2% · Below median
Dividend yield (TTM)0.0% · Bottom 25%
Balance sheet
Debt / equity0.45× · Highest 25%
Valuation Multiplesvs Farm Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Salmones Camanchaca S.A (SALMOCAM) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 3,961 CLP versus a price of 5,100 CLP, about −22% upside (overvalued).
What is the fair value of SALMOCAM?
Our model-based fair value for Salmones Camanchaca S.A is 3,961 CLP (as of Sep 24, 2026), built from audited fundamentals. The current price: 5,100 CLP.
What is the quality score of SALMOCAM?
Salmones Camanchaca S.A has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Salmones Camanchaca S.A (SALMOCAM)?
Our model-based price target is the fair value of 3,961 CLP (as of Sep 24, 2026) from 22 valuation models. Cautious scenario 2,518 CLP, optimistic scenario 6,202 CLP. It is a calculation from audited fundamentals, not an analyst target.
What is the Salmones Camanchaca S.A stock forecast for 2026?
Our models put fair value at 3,961 CLP, about −22% upside versus a price of 5,100 CLP (overvalued). Cautious scenario 2,518 CLP, optimistic scenario 6,202 CLP. The calculation is refreshed regularly with new filings.
What is the revenue of Salmones Camanchaca S.A (SALMOCAM)?
Salmones Camanchaca S.A reported trailing-twelve-month revenue of about $388M (latest available figure, as of Sep 24, 2026).
Does Salmones Camanchaca S.A pay a dividend?
Salmones Camanchaca S.A currently shows a dividend yield of about 0.00% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Salmones Camanchaca S.A (SALMOCAM)?
For today's price to be fair in a discounted-cash-flow model, Salmones Camanchaca S.A would have to grow free cash flow by more than 80 % per year for five years (discount rate 10.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.6 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of SALMOCAM use?
Our models discount Salmones Camanchaca S.A at 10.6 %: a base by market capitalisation (small), damped by beta 0.32, country premium for Chile. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Salmones Camanchaca S.A that is more than 80 % per year a year over ten years, using the same discount rate (10.6 %) and the same formula as our fair value.
How much growth has Salmones Camanchaca S.A (SALMOCAM) delivered so far?
Over the past 5 years revenue at Salmones Camanchaca S.A grew +8.6 % a year. The price currently implies more than 80 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Salmones Camanchaca S.A (SALMOCAM) growing?
The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Salmones Camanchaca S.A (more than 80 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Salmones Camanchaca S.A (SALMOCAM)?
The free-cash-flow yield on the price is 0.21 %: that much free cash flow Salmones Camanchaca S.A produces per unit of market value. When it exceeds the discount rate of our models (10.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Salmones Camanchaca S.A (SALMOCAM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Salmones Camanchaca S.A it is 3,961 CLP per share (as of Sep 24, 2026), against a price of 5,100 CLP. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Salmones Camanchaca S.A stock overvalued or undervalued in 2026?
As of Sep 24, 2026, SALMOCAM trades above its calculated fair value: price 5,100 CLP, fair value 3,961 CLP, a gap of about −22% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SALMOCAM?
No. The price is what the market pays today (5,100 CLP); the fair value is what the company's own numbers justify (3,961 CLP). For Salmones Camanchaca S.A the two are 1,139 CLP per share apart. That gap is exactly why we show both numbers side by side.
How much is Salmones Camanchaca S.A worth?
The market values Salmones Camanchaca S.A at about 378B CLP (market capitalisation, as of Sep 24, 2026). Per share that is 5,100 CLP; our models calculate a fair value of 3,961 CLP per share.
What do the bullish and bearish scenarios say about SALMOCAM?
Our models span a range for Salmones Camanchaca S.A: cautious scenario 2,518 CLP, base 3,961 CLP, optimistic 6,202 CLP per share (as of Sep 24, 2026, price 5,100 CLP). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SALMOCAM?
Salmones Camanchaca S.A trades at a price-to-earnings ratio of 23.7 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 3,961 CLP is built from several models across several years. Other multiples: P/B 1.8, P/S 1.0, EV/EBITDA 8.8.
How solid is the balance sheet of Salmones Camanchaca S.A (SALMOCAM)?
Balance-sheet figures for Salmones Camanchaca S.A (as of Sep 24, 2026): return on equity 8.2%, debt of 0.45 per unit of equity. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is SALMOCAM from its 52-week high?
Salmones Camanchaca S.A trades at 5,100 CLP, about 3% below its 52-week high of 5,255 CLP and 49% above the low of 3,428 CLP (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 3,961 CLP is for.
Which stocks are comparable to Salmones Camanchaca S.A?
From the same area (Consumer Defensive) we also value Archer-Daniels-Midland Company, Muyuan Foods Group, Bunge Global SA, Tyson Foods, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Salmones Camanchaca S.A stock attractive at the current price?
The data as of Sep 24, 2026: price 5,100 CLP, calculated fair value 3,961 CLP (−22%), Quality Score 64/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SALMOCAM calculated?
We run Salmones Camanchaca S.A through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 3,961 CLP, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Salmones Camanchaca S.A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Salmones Camanchaca S.A (SALMOCAM)?
The closing price on Sep 24, 2026 was 5,100 CLP. Our model-based fair value is 3,961 CLP, about −22% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Salmones Camanchaca S.A right now?
Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (2,518 CLP to 6,202 CLP) leaves room in how you read the outcome.
Key figures of Salmones Camanchaca S.A
How large is the market capitalisation of Salmones Camanchaca S.A (SALMOCAM)?
The market capitalisation of Salmones Camanchaca S.A is 378B CLP (≈ $394M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Salmones Camanchaca S.A (SALMOCAM)?
The price-to-sales ratio of Salmones Camanchaca S.A is 1.57 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Salmones Camanchaca S.A (SALMOCAM)?
Earnings per share at Salmones Camanchaca S.A are 214.93 CLP (price ÷ EPS = P/E 23.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Salmones Camanchaca S.A (SALMOCAM)?
The dividend yield of Salmones Camanchaca S.A is 0.0% (payout 0.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Salmones Camanchaca S.A (SALMOCAM)?
The net margin of Salmones Camanchaca S.A is 6.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Salmones Camanchaca S.A (SALMOCAM)?
The return on equity (ROE) of Salmones Camanchaca S.A is 8.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Salmones Camanchaca S.A (SALMOCAM)?
On an EBIT basis the return on assets of Salmones Camanchaca S.A is 5.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Salmones Camanchaca S.A (SALMOCAM)?
The operating margin of Salmones Camanchaca S.A is −3.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Salmones Camanchaca S.A (SALMOCAM)?
Revenue at Salmones Camanchaca S.A is growing +2.3% versus a year earlier (3y avg +1.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Salmones Camanchaca S.A (SALMOCAM)?
Earnings per share at Salmones Camanchaca S.A are growing −22.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Salmones Camanchaca S.A (SALMOCAM) carry?
The net debt of Salmones Camanchaca S.A is $92.7M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Salmones Camanchaca S.A in the live analysis
One click puts Salmones Camanchaca S.A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
